A person's race or ethnic background, gender or zip code shouldn’t determine whether they live or die from cancer, COVID-19 or any other disease. With your support of Fred Hutch, we can ensure all people get the prevention, treatment, care — and cures — they need.
Lifesaving research demands curiosity, creativity and varied perspectives. That’s why diversity is a core Fred Hutch value and integral to our work. We were the first U.S. cancer center to pledge commitment to CEO Action for Diversity & Inclusion, we cultivate a workplace that welcomes diverse perspectives and experiences, and we are committed to eliminating health disparities.
For more than two decades, Fred Hutch researchers have been making inroads against inequities in treatment and outcomes for people with cancer and other diseases, including COVID-19. But more significant investments are needed if we are to achieve our mission: ending the suffering caused by cancer and other diseases — not just for some people, but for everyone.
Precision medicine is imprecise when it comes to racial and ethnic minorities. Because these communities are underrepresented in most clinical trials and genetic studies, we’re missing opportunities to identify risk factors and develop effective treatments. By boosting inclusion, we are speeding our mission to find cures for all cancers in all people.
People from racial and ethnic minorities have higher rates of cancer and are more likely to die from the disease, while those who survive carry a heavier burden of negative health and economic impacts. To reduce these tremendous personal and economic costs, Fred Hutch researchers are using science to understand the factors that contribute to disparities and developing strategies to close the gaps.
Educating the next generation of researchers is mission-critical. We have developed inclusive and culturally relevant programs that attract students who are the first in their families to attend college, people with disabilities, veterans and those who belong to underrepresented racial or ethnic groups. By investing in education at Fred Hutch, you stoke dreams, strengthen science and lay the groundwork for future breakthroughs in cancer, HIV and other diseases.
Studies show that a lack of diversity among researchers contributes to cancer health disparities. Conversely, a diversity of experiences and perspectives unlocks wider-reaching and more innovative science. To ensure we’re doing the best research possible, and to better reflect the communities we serve, we are proactively building a more diverse workforce. Your support will help us become the employer of choice for people with new viewpoints and ideas who will help us achieve our mission faster.
The Office of Community Outreach and Engagement is reducing health disparities and addressing high rates of cancer and cancer mortality among underrpresented communities in Western Washington and the Yakima Valley.
The Hutchinson Institute for Cancer Outcomes Research works to improve cancer prevention, detection and treatment in ways that will reduce the economic and human burden of cancer — and ultimately lead to better outcomes for patients.
Dozens of Fred Hutch researchers are untangling causes of health disparities and developing solutions. Dr. Rachel Issaka is focused on reducing colorectal cancer deaths, especially for African-Americans, who are 40 percent more likely to die from the disease than whites.
— Dr. Thomas J. Lynch Jr., Fred Hutch president and director and holder of the Raisbeck Endowed Chair